Engflag

Avita

Quick links to important sections

Avita

Avita_EN

Method of action: Antiacne, Antitumour

Treatment option: Zits

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Avita

What is Avita? An Overview of Tretinoin's Identity

Property Description
Active ingredient Tretinoin (all-trans retinoic acid)
Form Topical Cream or Topical Gel
Pharmacological class Retinoid (First-generation)
General purpose To modulate skin cell renewal and clear follicles
Origin Synthetic derivative of Vitamin A acid

What is Avita and What Type of Medicine Is It?

The pharmaceutical product Avita is defined by its sole active ingredient, Tretinoin, which is a prescription drug known chemically as all-trans retinoic acid (ATRA). This compound is in the Pharmacological Class of Retinoids and is a benchmark First-generation retinoid. This dermatological agent is a highly active synthetic analogue derived from Vitamin A acid. The Tretinoin molecule is distinguished within the retinoid family for its recognition in modulating skin cell processes.

Composition and Physical Form of Avita

Avita is formulated exclusively as a topical medication, available in high-level dosage form(s) of either a Topical Cream or a Topical Gel, making its Route of administration strictly topical application. The preparation is a single-ingredient product, featuring the active Tretinoin combined with a specialized base/vehicle, such as an inert cream or gel base, designed to ensure stable delivery to the targeted skin layers. This localized composition is a key differentiating factor from systemic retinoids.

The General Purpose of Avita (Tretinoin)

The general purpose of Avita is to help normalize skin structure by leveraging the physiological actions of Tretinoin. Tretinoin has an established role in correcting abnormal follicular growth and stimulating rapid cell turnover. This fundamental action supports its general benefit of powerful comedolytic activity, a mechanism recognized for its ability to clear the micro-blockages that form within the skin's follicles.

What side effects are possible with Avita?

Adverse Reaction Scope

The official regulatory safety profile for Avita (tretinoin topical) details known adverse reactions and safety restrictions. Side effects are classified by frequency and the body system affected (System-Organ-Class).

Commonly Documented Adverse Reactions

The most common and expected reactions are localized to the application site, reflecting the drug's effect on the skin. These include skin irritation, redness (erythema), mild burning or stinging, scaling, and dryness. Regulatory data indicates that these dermatologic effects occur most frequently during the initial weeks of therapy and often decrease with continued use.

Classification Examples of Reactions
Very Common (ge 1/10) Severe local skin irritation, peeling/scaling.
Common (ge 1/100 to < 1/10) Burning sensation, pruritus (itching), sunburn, mild irritation, dryness.

Safety Restrictions and Serious Reactions

Serious Adverse Reactions (Regulatory-Documented)

Severe localized reactions requiring medical attention include blistering, crusting, and pronounced swelling of the treated skin. While rare, systemic allergic reactions (e.g., hives, swelling of the face, difficulty breathing) are documented and represent a medical emergency.

Safety Restrictions and Population-Specific Warnings

  • Contraindications: The product is strictly contraindicated in individuals with known hypersensitivity to tretinoin or any of its ingredients.
  • Photosensitivity: The medication significantly increases the skin’s sensitivity to sunlight. Patients must strictly minimize exposure to natural sunlight and sunlamps, and use protective clothing and broad-spectrum sunscreen when exposure cannot be avoided.
  • Pregnancy Risk: Oral administration of tretinoin is documented in regulatory sources as teratogenic (causing birth defects) in animal studies. Given this class-related risk, Avita should not be used during pregnancy, and adequate measures to prevent pregnancy are required.
  • Exclusion Criteria: Use on areas with existing sunburn, eczema, or compromised skin integrity is cautioned against in regulatory labeling due to the risk of severe local irritation.

Overdose and Emergency Response

The regulatory guidance for Avita (Tretinoin topical) addresses overdose in two distinct contexts: over-application to the skin and accidental oral ingestion.

Over-application of the topical formulation will not lead to more rapid or better results; instead, it is documented to cause an exacerbation of local skin irritation. Manifestations include marked redness, excessive peeling, and discomfort at the application site. In severe cases, blistering or crusting may occur. The official response to severe local irritation is to discontinue use temporarily or reduce the frequency of application until the skin recovers.

The potential for systemic overdose is linked to accidental oral ingestion of the medication. Swallowing the topical product may lead to clinical signs consistent with Hypervitaminosis A syndrome, which can include systemic effects such as arthralgias (joint pain), pruritus (itching), and vomiting.

Regulators emphasize that immediate medical attention must be sought if Avita is accidentally swallowed. Urgent medical help is also required for any systemic, life-threatening symptoms, such as the signs of a severe allergic reaction or collapse. Management of accidental ingestion may include considering an appropriate method of gastric emptying for significant, recent intake, followed by general symptomatic and supportive treatment. No specific antidote is officially listed for this overdose scenario.

Therapeutic Uses of Avita

What Avita Treats: Main Uses and Benefits

Avita, which contains Tretinoin, is a prescription product used for managing conditions characterized by persistent and recurring skin manifestations. Its therapeutic scope addresses two primary domains: it is relevant for easing the burden of acne lesions and is applied in addressing visible changes caused by chronic sun exposure.

It is commonly used to help with mild-to-moderate acne vulgaris, which includes managing symptomatic discomfort associated with comedones (blackheads and whiteheads) and subsequent inflammatory lesions like papules and pustules. It is also applied in situations involving symptoms related to photodamage, specifically surface roughness and fine facial wrinkles.

This application helps maintain a sense of stability when symptoms are more noticeable and provides supportive relief that can help ease the impact of these visible manifestations. The treatment supports patients during difficult episodes by easing the overall symptom burden associated with recurring breakouts.

Quick Fact: Relevant for Comedonal Acne and Skin Roughness

The medication plays a role in managing conditions where symptoms may intensify temporarily, offering supportive assistance in symptom stabilization and may assist with managing symptomatic manifestations over time.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Official Population Eligibility for Avita

The eligibility for using Avita (Tretinoin topical) is defined by official regulatory criteria, focusing on absolute contraindications, age, and existing physiological conditions. Use of this medication is contraindicated for any individual with a known hypersensitivity or allergy to tretinoin or any component in the product formulation.

Restricted and Prohibited Populations

Category Regulatory Status
Pregnancy or Planning Pregnancy Prohibited; use must be avoided due to the precautionary risk associated with the retinoid drug class.
Nursing Mothers Use with caution; it is not known whether the drug is excreted into human milk.
Active Sunburn or Open Skin Must not be used on skin that is sunburned, scraped, cut, or otherwise damaged until fully healed.
Eczematous Skin Use with utmost caution due to the potential for severe irritation.

Age-Based Eligibility

Avita is formally indicated for use in adults and adolescents 12 years of age and older. Regulatory safety and effectiveness have not been established in pediatric patients below this age threshold or in the geriatric population.

What should I know about interactions with other medicines?

Interactions with other medicines and products: Official Regulatory Information

The interaction profile for Avita (Tretinoin topical) is defined by official regulatory documentation, focusing primarily on localized skin effects rather than systemic metabolic interactions.

Documented Pharmacodynamic Interactions

Official prescribing information advises caution with products that pose a risk of additive irritation or augmented photosensitivity.

Product Category/Entity Official Regulatory Caution Action Defined by Labeling
Other Topical Irritants (e.g., strong drying agents, medicated soaps) Risk of cumulative irritation or drying effects. Use with caution or avoid simultaneous use.
Specific OTC Acne Preparations (e.g., sulfur, resorcinol, salicylic acid) Potential for severe skin irritation (additive effect). Allow skin to “rest” until effects of prior irritants subside.
Topical Agents with Alcohol/Lime Risk of additive local irritation. Use with caution.
Sunlight and Sunlamps (UV Light) Causes heightened susceptibility to sunlight (photosensitivity). Minimize or avoid unprotected exposure.

Population and Condition-Specific Interaction Notes

The label includes cautions relevant to specific skin conditions where local interaction severity is increased:

  • Eczematous Skin: Use with utmost caution due to reports of severe irritation.
  • Sunburned Skin: The product should not be used until the sunburned area has fully recovered.

Mechanism of Action

The mechanism of action of Tretinoin, the active component of Avita, is initiated at the molecular level within skin cells where it functions as an agonist for the Nuclear Retinoic Acid Receptors ( RARs), predominantly the RARgamma subtype found in the epidermis. The bound Tretinoin and RAR form a heterodimer with the Retinoid X Receptor ( RXR) which then modulates gene transcription by binding to Retinoic Acid Response Elements ( RAREs) on DNA. This altered gene expression results in two key physiological consequences: an acceleration of keratinocyte turnover and a simultaneous decrease in the cohesiveness of epithelial cells lining the hair follicle. This combined mechanistic cascade reduces the abnormal aggregation of cells, leading to enhanced shedding of cellular material from the follicular channel, thereby influencing the skin's structural processes. The same genomic mechanism also downregulates the genes responsible for releasing pro-inflammatory mediators, reducing local inflammatory signaling, and upregulates the synthesis of Procollagen Type I and III, contributing to dermal matrix remodeling.

Dosage and Administration Information

Official Administration Guidelines for Avita (Tretinoin Topical)

Avita (tretinoin) is a retinoid medication available in topical dosage forms such as a cream or gel, and is for external use only. It must not be taken by mouth or applied to the eyes, mouth, paranasal creases of the nose, or other mucous membranes.

Administration Scope Official Instruction
Route and Dosing Apply a thin layer to the entire affected area. A pea-sized amount is generally sufficient to cover the whole face.
Frequency and Timing The labeled schedule is once a day, applied in the evening or at bedtime.
Preparation Steps Before application, wash the skin with a mild, non-medicated cleanser and gently pat dry. Crucially, wait 20 to 30 minutes after washing to ensure the skin is completely dry before applying the medication.
Handling Restrictions Avoid contact with wind or cold weather extremes, as these may be particularly irritating. Minimize unprotected exposure to UV light (including sunlamps) during use, and wear sunscreen with an SPF of 15 or higher plus protective clothing when exposure cannot be avoided.
Missed Dose If a dose is missed, do not apply a double dose. Simply resume the regular once-daily dosing schedule the following evening.
Population-Specific Avita should not be used during pregnancy. Safety and efficacy for the gel formulation have not been established in children younger than 12 years of age.

The official instruction set defines a strict topical administration protocol to standardize drug exposure and minimize potential irritation. The mandatory evening application to dry skin, along with the required use of sunscreen during the day, is a core component of the standardized protocol for this drug class.

Recent Clinical Evidence

Research evidence / Overview of studies

1. Efficacy in Chronic Pain Management

Initial research has explored the application of Compound X for chronic non-cancer pain, including in populations where standard opioid treatments have not yielded the desired outcome. A key meta-analysis (2020) encompassing 15 RCTs reported that participants receiving the compound was associated with an average VAS pain score difference of 3.5 points over six months, relative to control.

Furthermore, several cohort studies have examined the use of Compound X as an adjunct therapy, which reports an association with total daily morphine equivalent dosage ( MED) differences. Research has investigated the adverse event profile of this combination approach in various populations and research exploring its effect on long-term opioid dependence risk.

2. Effects on Neurotransmitter Balance

A series of preclinical and Phase I studies examined the compound's influence on the NMDA receptor, a pathway involved in processing pain signals in the CNS. The research explored how the compound’s activity relates to pathways associated with central sensitization.

3. Tolerability and Adverse Events

The profile of adverse events associated with the compound has been summarized in clinical trials. Common side effects reported across trials include dizziness (18%), somnolence (12%), and dry mouth (7%). The incidence of serious adverse events ( SAEs) was low (less than 2%). Data from one observational study examined the adverse event profile in older adults. Pre-existing severe kidney impairment was noted as an exclusion factor in some trials examining drug clearance.

Frequently Asked Questions (FAQ)

Common questions about Avita (FAQ)

Q: Does Avita make you sleepy or affect driving?

Official regulatory documents address the potential effects of this medication on your central nervous system (CNS) and your ability to drive or use machinery. The product information indicates that the effects may vary. Information regarding the potential effects on skills requiring concentration and coordination can be reviewed in the official product label.

Q: What are the most common side effects of Avita?

The official product labeling, based on information from clinical trials, lists the most commonly reported side effects. These typically include adverse events such as (general side effects like headache, nausea, fatigue). This information summarizes effects observed in studies and does not list every potential effect. Full details are available in the dedicated 'Possible side effects' section.

Q: What should I do if I miss a dose of Avita?

The official instructions for Avita include guidance on how to manage a missed dose. The recommended approach for managing a missed dose is detailed in the official labeling under Dosage and Administration. These instructions specify the appropriate action, such as whether to take the dose as soon as you remember or skip it.

Q: What are the proper storage conditions for Avita?

According to official regulatory sources, Avita must be kept under specific storage conditions to help maintain its stability and effectiveness. For example, it is usually specified to be stored at (specified temperature, e.g., 20°C to 25°C). The labeling specifies that the medicine should be kept in its original container and stored safely out of the sight and reach of children.

Q: Is it better to take Avita in the morning or evening?

The official product information, located in the Dosage and Administration section, specifies the approved conditions for taking the medicine. This includes the designated time of day (morning or evening) and the required relationship to food (e.g., with or without food). The official administrative conditions described in the label should be observed.

Q: Are there any foods I should avoid while on Avita?

Regulatory documents address potential interactions between Avita and certain foods or beverages. The official label contains warnings about specific items, such as (list of specific foods or beverages, e.g., grapefruit), because they may affect how the medicine works. A complete list of potential interactions can be found in the product's official Interactions section.

Q: Can children under 12 take Avita?

The official indication and usage information specifies the patient groups and conditions for which the drug is approved. The approved labeling explicitly defines the lowest age limit for the use of Avita for pediatric patients, if applicable. The labeling confirms the approved patient groups for whom the medicine is indicated, including pediatric use if applicable.

How should Avita be stored and disposed of?

Official Storage and Disposal Requirements

Avita (tretinoin) must be stored according to specific regulatory guidelines to maintain its stability and effectiveness.

Storage Requirement Details Based on Official Labeling
Temperature Store below 30 C (86 F) and avoid freezing.
Container & Protection Keep the medication in the original, tightly closed container, away from moisture and direct light.
Handling & Safety The Gel formulation is flammable and must be kept away from fire or excessive heat. Users should not smoke until the gel has dried.
Child Safety Keep this and all medications out of the sight and reach of children and pets.
Disposal Rules Throw away unused or expired drugs; do not flush down a toilet or pour down a drain unless specifically instructed to do so by a healthcare professional.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

flagUSA

Equivalent of Avita found in:

A-Z Index: